• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性硬膜下血肿清除术后硬膜下引流时间的全国随机临床试验。

National randomized clinical trial on subdural drainage time after chronic subdural hematoma evacuation.

作者信息

Jensen Thorbjørn Søren Rønn, Haldrup Mette, Hjortdal Grønhøj Mads, Miscov Rares, Larsen Carl Christian, Debrabant Birgit, Poulsen Frantz Rom, Bergholt Bo, Hundsholt Torben, Bjarkam Carsten Reidies, Fugleholm Kåre

机构信息

1Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark.

3Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark.

出版信息

J Neurosurg. 2021 Dec 31;137(3):799-806. doi: 10.3171/2021.10.JNS211608. Print 2022 Sep 1.

DOI:10.3171/2021.10.JNS211608
PMID:34972091
Abstract

OBJECTIVE

Placement of a subdural drain reduces recurrence and death after evacuation of chronic subdural hematoma (CSDH), but little is known about optimal drainage duration. In the present national trial, the authors investigated the effect of drainage duration on recurrence and death.

METHODS

In a randomized controlled trial involving all neurosurgical departments in Denmark, patients treated with single burr hole evacuation of CSDH were randomly assigned to 24 hours or 48 hours of postoperative passive subdural drainage. Follow-up duration was 90 days, and the primary study outcome was recurrent hematoma requiring reoperation. Secondary outcome was death. In addition, complications and length of hospital stay were recorded and analyzed.

RESULTS

Of the 420 included patients, 212 were assigned 24-hour drainage and 208 were assigned 48-hour drainage. The recurrence rate was 14% in the 24-hour group and 13% in the 48-hour group. Four patients died in the 24-hour group, and 8 patients died in the 48-hour group; this difference was not statistically significant. The ORs (95% CIs) for recurrence and mortality (48 hours vs 24 hours) were 0.94 (0.53-1.66) and 2.07 (0.64-7.85), respectively, in the intention-to-treat analysis. The ORs (95% CIs) for recurrence and mortality per 1-hour increase in drainage time were 1.0005 (0.9770-1.0244) and 1.0046 (0.9564-1.0554), respectively, in the as-treated sensitivity analysis that used the observed drainage times instead of the preassigned treatment groups. The rates of surgical and drain-related complications, postoperative infections, and thromboembolic events were not different between groups. The mean ± SD postoperative length of hospital stay was 7.4 ± 4.3 days for patients who received 24-hour drainage versus 8.4 ± 4.9 days for those who received 48-hour drainage (p = 0.14). The mean ± SD postoperative length of stay in the neurosurgical department was significantly shorter for the 24-hour group (2 ± 0.9 days vs 2.8 ± 1.6 days, p < 0.001).

CONCLUSIONS

No significant differences in the rates of recurrent hematoma or death during 90-day follow-up were identified between the two groups that randomly received either 24- or 48-hour passive subdural drainage after burr hole evacuation of CSDH.

摘要

目的

放置硬膜下引流管可降低慢性硬膜下血肿(CSDH)引流术后的复发率和死亡率,但对于最佳引流持续时间知之甚少。在本次全国性试验中,作者研究了引流持续时间对复发率和死亡率的影响。

方法

在一项涉及丹麦所有神经外科科室的随机对照试验中,接受单孔钻颅引流CSDH治疗的患者被随机分配至术后24小时或48小时的被动硬膜下引流。随访期为90天,主要研究结局为需要再次手术的复发性血肿。次要结局为死亡。此外,记录并分析并发症和住院时间。

结果

420例纳入患者中,212例被分配至24小时引流组,208例被分配至48小时引流组。24小时组的复发率为14%,48小时组为13%。24小时组有4例患者死亡,48小时组有8例患者死亡;差异无统计学意义。在意向性分析中,复发和死亡的比值比(95%可信区间)(48小时 vs 24小时)分别为0.94(0.53 - 1.66)和2.07(0.64 - 7.85)。在使用观察到的引流时间而非预先指定的治疗组的实际治疗敏感性分析中,每增加1小时引流时间,复发和死亡的比值比(95%可信区间)分别为1.0005(0.9770 - 1.0244)和1.0046(0.9564 - 1.0554)。两组之间手术及与引流相关的并发症、术后感染和血栓栓塞事件的发生率无差异。接受24小时引流的患者术后平均住院时间±标准差为7.4 ± 4.3天,而接受48小时引流的患者为8.4 ± 4.9天(p = 0.14)。24小时组在神经外科的术后平均住院时间±标准差显著更短(2 ± 0.9天 vs 2.8 ±  1.6天,p < 0.001)。

结论

在CSDH钻孔引流术后随机接受24小时或48小时被动硬膜下引流的两组患者中,90天随访期间复发性血肿或死亡率无显著差异。

相似文献

1
National randomized clinical trial on subdural drainage time after chronic subdural hematoma evacuation.慢性硬膜下血肿清除术后硬膜下引流时间的全国随机临床试验。
J Neurosurg. 2021 Dec 31;137(3):799-806. doi: 10.3171/2021.10.JNS211608. Print 2022 Sep 1.
2
Postoperative drainage for 6, 12, or 24 h after burr-hole evacuation of chronic subdural hematoma in symptomatic patients (DRAIN-TIME 2): study protocol for a nationwide randomized controlled trial.慢性硬脑膜下血肿钻孔引流术后 6、12 或 24 小时引流:一项全国范围内随机对照试验的研究方案。
Trials. 2022 Mar 14;23(1):213. doi: 10.1186/s13063-022-06150-x.
3
Subdural drainage techniques for single burr-hole evacuation of chronic subdural hematoma: two drains frontal-occipital position versus one drain frontal position.单骨孔引流术治疗慢性硬脑膜下血肿的硬膜下引流技术:双引流额枕位与单引流额位的比较。
Br J Neurosurg. 2021 Jun;35(3):324-328. doi: 10.1080/02688697.2020.1812520. Epub 2020 Sep 1.
4
Subperiosteal vs Subdural Drain After Burr-Hole Drainage of Chronic Subdural Hematoma: A Randomized Clinical Trial (cSDH-Drain-Trial).颅骨钻孔引流慢性硬脑膜下血肿后骨膜下与硬膜下引流的随机临床试验(cSDH-Drain-Trial)。
Neurosurgery. 2019 Nov 1;85(5):E825-E834. doi: 10.1093/neuros/nyz095.
5
Early spontaneous cessation of subdural drainage after burr hole evacuation of chronic subdural hematoma and risk of recurrence.慢性硬脑膜下血肿颅骨钻孔引流术后早期自发性停止引流与复发风险。
PLoS One. 2023 May 17;18(5):e0285750. doi: 10.1371/journal.pone.0285750. eCollection 2023.
6
Drain type after burr-hole drainage of chronic subdural hematoma in geriatric patients: a subanalysis of the cSDH-Drain randomized controlled trial.老年慢性硬脑膜下血肿患者颅骨钻孔引流术后的引流类型:cSDH-Drain 随机对照试验的亚分析。
Neurosurg Focus. 2020 Oct;49(4):E6. doi: 10.3171/2020.7.FOCUS20489.
7
Finnish study of intraoperative irrigation versus drain alone after evacuation of chronic subdural haematoma (FINISH): a study protocol for a multicentre randomised controlled trial.芬兰研究慢性硬脑膜下血肿引流术后术中冲洗与单纯引流的效果(FINISH):一项多中心随机对照试验的研究方案。
BMJ Open. 2020 Jun 21;10(6):e038275. doi: 10.1136/bmjopen-2020-038275.
8
Efficacy of Trauma Catheter and Mushroom Tip Catheter in Evacuation of Chronic Subdural Hematoma and Complications of Drain Placement.创伤导管和蘑菇头导管在慢性硬膜下血肿引流及引流管置入并发症中的疗效
Cureus. 2019 Jul 11;11(7):e5123. doi: 10.7759/cureus.5123.
9
Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in Denmark.慢性硬脑膜下血肿清除术后最佳引流时间(DRAIN TIME 2):丹麦多中心、随机、多臂、多阶段非劣效性试验。
Lancet Neurol. 2024 Aug;23(8):787-796. doi: 10.1016/S1474-4422(24)00175-3. Epub 2024 Jun 12.
10
Transition of a Clinical Practice to Use of Subdural Drains after Burr Hole Evacuation of Chronic Subdural Hematoma: The Helsinki Experience.慢性硬脑膜下血肿颅骨钻孔引流术后使用硬膜下引流的临床实践转变:赫尔辛基经验。
World Neurosurg. 2019 Sep;129:e614-e626. doi: 10.1016/j.wneu.2019.05.230. Epub 2019 May 31.

引用本文的文献

1
Intracranial pressure changes during early postoperative mobilization in patients with chronic subdural hematoma.慢性硬膜下血肿患者术后早期活动期间的颅内压变化
Acta Neurochir (Wien). 2025 Sep 1;167(1):234. doi: 10.1007/s00701-025-06655-9.
2
Efficacy of atorvastatin-based treatment in super-aged patients with chronic subdural hematoma: a case series and literature review.阿托伐他汀治疗高龄慢性硬膜下血肿患者的疗效:病例系列研究与文献综述
Front Neurol. 2025 Jun 27;16:1609514. doi: 10.3389/fneur.2025.1609514. eCollection 2025.
3
Antithrombotic Therapy After Burr Hole Evacuation of Chronic Subdural Hematoma: A Post Hoc Analysis of 2 Randomized Clinical Trials.
慢性硬膜下血肿钻孔引流术后的抗栓治疗:两项随机临床试验的事后分析
JAMA Neurol. 2025 Jul 1;82(7):749-751. doi: 10.1001/jamaneurol.2025.1433.
4
Letter-to-the-editor to the study by Bartek J "Multidisciplinary consensus-based statement on the current role of Middle Meningeal Artery embolization (MMAE) in chronic SubDural Hematoma (cSDH)" - A letter from the international CSDH research group committee, iCORIC.致编辑的信:关于巴特克·J的研究《基于多学科共识的关于脑膜中动脉栓塞术(MMAE)在慢性硬膜下血肿(cSDH)当前作用的声明》——来自国际慢性硬膜下血肿研究小组委员会iCORIC的一封信
Brain Spine. 2024 Dec 24;5:104169. doi: 10.1016/j.bas.2024.104169. eCollection 2025.
5
Association between postoperative thromboembolic and hemorrhagic complications and clinical outcomes after surgery for chronic subdural hematoma in patients with anticoagulation therapy for atrial fibrillation.心房颤动抗凝治疗患者慢性硬膜下血肿手术后血栓栓塞和出血并发症与临床结局之间的关联
Acta Neurochir (Wien). 2025 Jan 16;167(1):17. doi: 10.1007/s00701-024-06417-z.
6
Letter to the Editor: Commentary on Factors Associated With Short-Term Outcomes of Burr-Hole Craniostomy Associated With Brain Re-Expansion and Subdural Hematoma Shrinkage for Chronic Subdural Hematoma ( 2023;19:324-332).致编辑的信:关于慢性硬膜下血肿钻孔开颅术与脑再膨胀及硬膜下血肿缩小的短期结局相关因素的评论(2023;19:324 - 332)
Korean J Neurotrauma. 2024 Dec 13;20(4):305-306. doi: 10.13004/kjnt.2024.20.e38. eCollection 2024 Dec.
7
Inflammatory Risk Factors for Chronic Subdural Hematoma in a Nationwide Cohort.全国队列中慢性硬膜下血肿的炎症风险因素
J Inflamm Res. 2024 Nov 6;17:8261-8270. doi: 10.2147/JIR.S472849. eCollection 2024.
8
Predicting the progression of chronic subdural hematoma based on skull density.基于颅骨密度预测慢性硬膜下血肿的进展
Front Neurol. 2023 Oct 20;14:1279292. doi: 10.3389/fneur.2023.1279292. eCollection 2023.
9
Surgical techniques for evacuation of chronic subdural hematoma: a mini-review.慢性硬膜下血肿清除术的手术技术:一篇综述
Front Neurol. 2023 Jun 28;14:1086645. doi: 10.3389/fneur.2023.1086645. eCollection 2023.
10
Chronic subdural hematoma drainage using anti-thrombotic catheter technique.使用抗血栓导管技术进行慢性硬膜下血肿引流
World Neurosurg X. 2023 May 19;19:100215. doi: 10.1016/j.wnsx.2023.100215. eCollection 2023 Jul.